[HTML][HTML] High prevalence of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: a cross-sectional study

M López-Sánchez, M Muñoz-Esquerre, D Huertas… - PloS one, 2013 - journals.plos.org
Background A subclinical left ventricle diastolic dysfunction (LVDD) has been described in
patients with chronic obstructive pulmonary disease (COPD). Objectives To evaluate the …

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation

…, M López-Sánchez, M Muñoz-Esquerre… - … journal of chronic …, 2016 - Taylor & Francis
Exacerbations of COPD represent an important medical and health care problem. Certain
susceptible patients suffer recurrent exacerbations and as a consequence have a poorer …

Comparative effectiveness of anti‐IL5 and anti‐IgE biologic classes in patients with severe asthma eligible for both

…, BG Cosio, DR Dorscheid, M MuñozEsquerre… - Allergy, 2023 - Wiley Online Library
Background Patients with severe asthma may present with characteristics representing
overlapping phenotypes, making them eligible for more than one class of biologic. Our aim was …

[HTML][HTML] Sudan red dye: a new agent causing type-2 occupational asthma

D Clofent, M de Homdedeu, M Muñoz-Esquerre… - Allergy, Asthma & …, 2020 - Springer
Background Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol is a low molecular weight
azoic agent widely used in industry, particularly in the production of hair dyes. The use of this …

Roflumilast added to triple therapy in patients with severe COPD: a real life study

M Muñoz-Esquerre, M Diez-Ferrer, C Montón… - Pulmonary …, 2015 - Elsevier
Background Roflumilast is used in severe chronic obstructive pulmonary disease (COPD)
patients with frequent exacerbations. However, limited information is available on its impact in …

[HTML][HTML] Systemic and pulmonary vascular remodelling in chronic obstructive pulmonary disease

M Muñoz-Esquerre, M López-Sánchez, I Escobar… - PLoS …, 2016 - journals.plos.org
Background Chronic Obstructive Pulmonary Disease (COPD) is associated with subclinical
systemic atherosclerosis and pulmonary vascular remodelling characterized by intimal …

Factors associated with suboptimal response to monoclonal antibodies in severe asthma

LP de Llano, NM Malanda, I Urrutia… - …, 2023 - pubmed.ncbi.nlm.nih.gov
… 6 , Mariana Muñoz Esquerre

[HTML][HTML] Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD

E Aliagas, M Muñoz-Esquerre, E Cuevas, O Careta… - Respiratory …, 2018 - Springer
Background Extracellular adenosine triphosphate (ATP) is up-regulated in the airways of
patients with chronic obstructive pulmonary disease (COPD), resulting in increased …

The response to biologics is better in patients with severe asthma than in patients with asthma–COPD overlap syndrome

…, JA Gullón Blanco, M Muñoz-Esquerre… - Journal of Asthma …, 2022 - Taylor & Francis
Although biologics have demonstrated to be effective in T2-high asthma patients, there is little
experience with these drugs in asthma–COPD overlap (ACO). The aim of this study was to …

Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction

M López‐Sánchez, M MuñozEsquerre… - The clinical …, 2017 - Wiley Online Library
Background Left ventricular diastolic dysfunction (LVDD) is a frequent condition in chronic
obstructive pulmonary disease (COPD). Tenascin‐C (Tn‐C) and matrix metalloproteinase‐9 (…